Trial · NCT00241124
Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
NCT00241124, Phase 4, Completed, Novartis
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes. Trials, record NCT00241124. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00241124
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
- NCT number
- NCT00241124
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 1,099 participants, actual
- Lead sponsor
- Novartis
- Conditions
- Hypertension
- Interventions
- valsartan, lisinopril
- First posted
- 2005-10-18
- Last updated
- 2011-11-23
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Average 24 hour blood pressure less than 130/80 mmHg after 26 weeks | ||
| Primary | Change from baseline in systolic 24 hour blood pressure after 12 weeks | ||
| Secondary | Change from baseline manual blood pressure and pulse pressure after 26 weeks | ||
| Secondary | Change from baseline markers of endothelial function, fibrosis, and other blood measurements of hypertension after 12 and 26 weeks | ||
| Secondary | Changes in ambulatory blood pressure measurements at various timepoints up to 26 weeks | ||
| Secondary | Change from baseline heart size after 26 weeks | ||
| Secondary | Adverse events, serious adverse events, laboratory values, physical examinations, vital signs for up to 26 weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 25259546 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00241124
GET https://conductscience.org/api/trials/v1/NCT00241124/registered